PAK6 has been reported to be an important tumor suppressor in prostate cancer cells based on its ability to phosphorylate the androgen receptor [42, 43], tumorigenic E3 ligase murine double minute-2 (Mdm2) [43], and β-catenin [44]. This evidence concerns the gene AR and prostate carcinoma.